Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年1月28日
	新闻
	Breaking Down the CONVERGE Study of NBTXR3 in Stage 3 Unresectable NSCLC Cure Today The first participant has been dosed on the phase 2 CONVERGE study evaluating NBTXR3 in stage III, unresectable non–small cell lung cancer. 标记为不相关
	A Close Look at Clinical Trials in Oncology and Beyond: Incorporating Into Standard Care OncLive My name is Richard Carvajal; I'm a medical oncologist. I have the role of deputy physician-in-chief, here, at the Northwell Health Cancer Institute, ... 标记为不相关
	Median Technologies and European Investment Bank agrees to €37.5M loan Mugglehead Investment Magazine ... Lung Cancer Screening (LCS) Software. Additionally, Median and the EIB have agreed to extend the maturity of the company's existing 2020 loan by ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈